Peripheral Intravenous Catheter Market, By Product Type (Short PIVC (Ported PIVC, Non-ported PIVC), Integrated/Closed PIVC), By Technology (Conventional, Safety), By End User (Hospital, Clinics, Ambulatory Surgical Centers, Homecare Settings, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : Oct 2023

Code : CMI3208

Pages :180

Formats :

Excel and PDF

Industry : Medical Devices

Market Challenges And Opportunities

Restraints & Challenges:

Complications associated with peripheral intravenous catheter

Global Peripheral Intravenous Catheter Market- Drivers

Increasing prevalence of major diseases: Increasing incidence of major diseases such as cancer, cardiac disorders, orthopedic disorders, etc. is expected to propel growth of the global peripheral intravenous catheter market over the forecast period. For instance, in September 2022, according to an article published by the National Center for Biotechnology Information (NCBI) Journal, the age-standardized point prevalence and annual incidence rates of orthopedic disorders and dysfunctions were 446.6 and 24.9 in 2021, indicating increase by 12.4% and 9.9% from 2010. Out of which, around 7,522 cartilage restoration procedures had been reported by the surgeons in the U.S.

Global Peripheral Intravenous Catheter Market- Cross Sectional Analysis

Key players are focusing on inorganic strategies such as agreements, and this is expected to drive the peripheral intravenous catheter market in North America region. For instance, on February 23, 2023, Medsource Labs., a medical product developer and supplier, announced that the company had been awarded a group purchasing agreement for Peripheral Intravenous Catheters (PIVC) solutions with Premier's AscenDrive program, that is designed to drive the highest-level commitment and savings for members through aggregated purchasing of high-quality products and services.

Global Peripheral Intravenous Catheter Market: Restraint

Complications associated with peripheral intravenous catheter: Complications associated with peripheral intravenous catheter is expected to hinder the market growth over the forecast period. For instance, in January 2021, according to a report published by BioMed Central Ltd, an open access scientific publisher, the most common and important PIVC-related complication include phlebitis, which occurs with 7–44% of catheters. The occurrence of Phlebitis, unintentional removal, occlusion, thrombosis, and catheter-related blood stream infection (CRBSI) are among the PIVC-related problems that might happen (20–50%).
Counterbalance: Key players are focusing on developing advance products with safety which is expected to drive the market growth over the forecast period.